Table 3. Internal consistency and test-retest reliability of the Reflux Disease Questionnaire electronic Diary.
PRO Validation Study |
Dose-finding Study |
|||
---|---|---|---|---|
Domain | Cronbach's alpha (95% CI) (n=580) | ICC (95% CI) (n=126) | Cronbach's alpha (95% CI) (n=625) | ICC (95% CI) (n=188) |
Heartburn | 0.94 (0.94–0.95) | 0.65 (0.54–0.74) | 0.93 (0.92–0.94) | 0.80 (0.75–0.85) |
Regurgitation | 0.95 (0.94–0.96) | 0.74 (0.65–0.81) | 0.89 (0.88–0.91) | 0.81 (0.75–0.85) |
Hoarseness, cough, difficulty swallowing | 0.89 (0.87–0.91) | 0.85 (0.79–0.89) | 0.85 (0.83–0.87) | 0.85 (0.81–0.89) |
Burping | NA | 0.73 (0.63–0.8) | NA | 0.77 (0.70–0.82) |
Overall symptoms | 0.96 (0.95–0.96) | 0.75 (0.66–0.82) | 0.93 (0.92–0.93) | 0.81 (0.75–0.85) |
CI, confidence interval; ICC, intraclass correlation coefficient; NA, not applicable (single item domain); PRO, patient-reported outcome.